ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

REGN Regeneron Pharmaceuticals Inc

892.79
0.31 (0.03%)
Last Updated: 13:11:46
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.99B2.87B2.98B3.42B3.16B3.16B3.36B3.43B
Operating Income 1.26B1.18B1.26B1.05B946.7M1.02B1.11B972.9M
Pre Tax Income 1.06B963.2M1.51B1.32B858M1.08B1.11B1.15B
Net Income 973.5M852.1M1.32B1.2B817.8M968.4M1.01B1.16B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 1.29B1.21B1.12B1.1B876M1.03B1.13B920.7M
EBITDA 1.33B1.25B1.35B1.15B1.05B1.12B1.22B1.09B
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 4.86B5.87B6.71B7.86B8.78B16.12B12.26B13.12B
Operating Income 1.33B2.08B2.53B2.21B3.58B8.95B4.74B4.05B
Pre Tax Income 1.33B2.08B2.55B2.43B3.81B9.33B4.86B4.2B
Net Income 895.52M1.2B2.44B2.12B3.51B8.08B4.34B3.95B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 4.1785.32410.7059.49216.24636.75719.58217.951
EBIT 1.34B2.1B2.58B2.34B3.67B9B4.8B4.03B
EBITDA 1.44B2.22B2.68B2.42B3.81B9.23B5.08B4.47B

Your Recent History

Delayed Upgrade Clock